DK0499399T3 - Analgetiske præparater - Google Patents

Analgetiske præparater

Info

Publication number
DK0499399T3
DK0499399T3 DK92300987.2T DK92300987T DK0499399T3 DK 0499399 T3 DK0499399 T3 DK 0499399T3 DK 92300987 T DK92300987 T DK 92300987T DK 0499399 T3 DK0499399 T3 DK 0499399T3
Authority
DK
Denmark
Prior art keywords
ibuprofen
composition
weight
water
oil
Prior art date
Application number
DK92300987.2T
Other languages
Danish (da)
English (en)
Inventor
Dhiraj Shantilal Mody
Robert George Blank
Gary Robert Agasim
Gloria Yoshiko Chen
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of DK0499399T3 publication Critical patent/DK0499399T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/02Halogenated hydrocarbons
    • A61K31/025Halogenated hydrocarbons carbocyclic
    • A61K31/03Halogenated hydrocarbons carbocyclic aromatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK92300987.2T 1991-02-11 1992-02-06 Analgetiske præparater DK0499399T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65411791A 1991-02-11 1991-02-11
US74101191A 1991-08-06 1991-08-06
US07/814,995 US5210099A (en) 1991-02-11 1992-01-08 Analgesic compositions

Publications (1)

Publication Number Publication Date
DK0499399T3 true DK0499399T3 (da) 1997-02-03

Family

ID=27417914

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92300987.2T DK0499399T3 (da) 1991-02-11 1992-02-06 Analgetiske præparater

Country Status (18)

Country Link
US (1) US5210099A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0499399B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0558884A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR920016087A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE147624T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU650946B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2060833C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69216650T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0499399T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2096712T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI100856B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3022886T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE920245A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9200554A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO179273C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ241547A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW225987B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UY (1) UY23373A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
DE4405641C2 (de) * 1994-02-22 1997-04-30 Roemmers Sa Pharmazeutische Zusammensetzung, enthaltend 2-(4-Methoxyphenoxy)-3-pyridinamin
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
ES2118033B1 (es) * 1996-02-16 1999-07-01 Bial Ind Farmaceutica S A Formulacion farmaceutica antiinflamatoria.
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US6083996A (en) * 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
WO1999026571A1 (en) * 1997-11-25 1999-06-03 Theratech, Inc. Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
US6368618B1 (en) * 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
KR20040066096A (ko) * 2001-10-04 2004-07-23 매크로켐 코포레이션 이부프로펜 염 유화제 및 이를 함유하는 크림 조성물
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
AU2005216192B2 (en) * 2004-02-23 2010-11-04 Strategic Science & Technologies, Llc Topical delivery of a nitric oxide donor to improve body and skin appearance
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
EP1737429B1 (en) * 2004-04-19 2013-07-17 Strategic Science & Technologies, LLC Transdermal delivery of beneficial substances effected by a high ionic strength environment
US20090105336A1 (en) * 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
EP1785131A4 (en) * 2004-08-31 2009-03-11 Aspion Co Ltd EXTERNAL PREPARATION OF TYPE S / O
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
US20070098660A1 (en) * 2005-10-27 2007-05-03 Jim Taneri Methods and compositions for epilation
US20080095831A1 (en) * 2006-08-10 2008-04-24 Mc Graw Thomas L Topical formulation of multilamellar vesicles composition for percutaneous absorption of pharmaceutically active agent
US20090306025A1 (en) * 2008-05-30 2009-12-10 Fairfield Clinical Trials, Llc Method and composition for skin inflammation and discoloration
CA2749941C (en) 2008-09-10 2018-04-24 Biochemics, Inc. Ibuprofen for topical administration
EP2207536A1 (en) 2008-09-22 2010-07-21 BioChemics, Inc. Transdermal drug delivery using an osmolyte and vasoactive agent
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
US20100099775A1 (en) * 2008-10-17 2010-04-22 Alpharx Inc. Method for ameliorating of post-anesthetic recovery
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US9072659B2 (en) 2009-06-24 2015-07-07 Strategic Science & Technologies, Llc Topical composition containing naproxen
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2012092528A1 (en) 2010-12-29 2012-07-05 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP3045171A1 (en) * 2009-06-24 2016-07-20 Strategic Science & Technologies, LLC Topical composition
US8895536B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating chronic inflammation and inflammatory diseases
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
JP2014501283A (ja) 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ, エルエルシー アレルギーおよび他の適応症の処置のためのシステムおよび方法
EP2827839B1 (en) 2012-03-20 2019-02-27 Particle Dynamics International, LLC Gelling agent-based dosage form
JP6121796B2 (ja) * 2012-05-23 2017-04-26 キユーピー株式会社 脂肪乳剤および医薬品組成物中の非ステロイド性抗炎症薬の含有量を高める方法
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
EP3268085A4 (en) 2015-03-13 2018-10-31 The Board of Trustees of The Leland Stanford Junior University Ltb4 inhibition to prevent and treat human lymphedema
WO2019112848A1 (en) 2017-12-04 2019-06-13 Johnson & Johnson Consumer Inc. Topical emulsion composition containing nonsteroidal anti-inflammatory drug

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2742396A (en) * 1952-08-13 1956-04-17 Purdue Research Foundation Ointment base
CA727589A (en) * 1962-12-27 1966-02-08 Braun Ernest Depilatory composition
US4385049A (en) * 1981-05-12 1983-05-24 K-V Pharmaceutical Company Stable high internal phase ratio topical emulsions
JPS5829706A (ja) * 1981-08-14 1983-02-22 Toko Yakuhin Kogyo Kk 消炎鎮痛外用剤
JPS59139315A (ja) * 1983-01-31 1984-08-10 Taisho Pharmaceut Co Ltd クリ−ム剤
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel

Also Published As

Publication number Publication date
NO920527D0 (no) 1992-02-10
EP0499399B1 (en) 1997-01-15
EP0499399A1 (en) 1992-08-19
DE69216650D1 (de) 1997-02-27
ES2096712T3 (es) 1997-03-16
NO179273C (no) 1996-09-11
JPH0558884A (ja) 1993-03-09
FI920523A0 (fi) 1992-02-07
IE920245A1 (en) 1992-08-12
NZ241547A (en) 1993-02-25
FI100856B (fi) 1998-03-13
ATE147624T1 (de) 1997-02-15
NO920527L (no) 1992-08-12
KR920016087A (ko) 1992-09-24
MX9200554A (es) 1992-08-01
CA2060833C (en) 1997-12-30
TW225987B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-07-01
US5210099A (en) 1993-05-11
DE69216650T2 (de) 1997-05-07
NO179273B (no) 1996-06-03
FI920523L (fi) 1992-08-12
AU650946B2 (en) 1994-07-07
AU1073092A (en) 1992-08-13
GR3022886T3 (en) 1997-06-30
CA2060833A1 (en) 1992-08-12
UY23373A1 (es) 1992-07-23

Similar Documents

Publication Publication Date Title
DK0499399T3 (da) Analgetiske præparater
DE69020211D1 (de) Kosmetische Doppelemulsionszusammensetzung.
OA05820A (fr) Concentré pour la préparation de microémulsions d'huile et d'eau de forte salinité.
MY113936A (en) Solutions and their preparation
DE3176125D1 (en) 1-carboxyalkanoylindolin-2-carboxylic acids and derivatives thereof, processes for their preparation, and pharmaceutical compositions containing these compounds
FI981654A0 (fi) Rasvaliukoisia aineita sisältäviä stabiileja valmisteita
CA2019516A1 (en) Method of Oil Well Corrosion Inhibition Via Emulsions and Emulsions Therefor
NO910399L (no) Anvendelse av trialkanolaminpolyetere som demulgatorer for olje-i-vann-emulsjoner.
DK0530505T3 (da) Hydantoinderivater
BE888082A (fr) Compositions cosmetiques ou pharmaceutiques sous forme d'emulsions stables du type huile-dans-l'eau
DK44789D0 (da) Olie-i-vand emulsion og fremgangsmaade til fremstilling deraf
DE3870409D1 (de) Alkoholfreie fluessige make up-zusammensetzung.
FI113739B (fi) Öljy vedessä -emulsioita mikrobisidien (biosidien) korvaajina vettä sisältävissä systeemeissä
NO842665L (no) Biopolymerer og fremgangsmaate for deres fremstilling
FR2451163A1 (fr) Emulsion insecticide huile-dans-eau et son procede de preparation
LU78001A1 (fr) Nouvelles compositions cosmetiques sous forme d'emulsions eau-dans-l'huile ou huile-dans-l'eau
ATE139435T1 (de) Kosmetische und dermatologische zubereitungen
KR920703047A (ko) 트리글리세라이드를 함유하는 포도필로톡신 제제
AU532338B2 (en) Stabilised liquid herbicide
BR9813281A (pt) Compostos de 4,5-diariloxazol, processos para sua preparação, composição farmacêutica contendo o mesmo, e seu uso
FR2681247B1 (fr) Composition pharmaceutique pour application topique contenant du dithranol et procede de preparation.
BE826563A (fr) Coalescence de l'huile dans des emulsions huile-dans-eau
DE29814159U1 (de) Minerot-Oetinger, Mineralmischung (Elektrolytmischung)
TH7270A (th) สารผสมสำหรับเพิ่มน้ำหนัก